essential hypertension
Showing 1 - 25 of 213
Essential Hypertension Trial (NW Roselle, Captopril 25Mg Tab)
Not yet recruiting
- Essential Hypertension
- NW Roselle
- Captopril 25Mg Tab
- (no location specified)
Nov 15, 2023
S-amlodipine in Essential HypertensIon and Assessment of Blood
Recruiting
- Essential Hypertension
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofBundang Seoul University Hospital
Nov 8, 2023
Essential Hypertension Trial in Seoul (D064 and D702, QD, D064 and Placebo of D702, QD, Placebo of D064 and D702, QD)
Recruiting
- Essential Hypertension
- D064 and D702, QD
- +2 more
-
Seoul, Seongdong-gu, Korea, Republic ofHanyang University Seoul Hospital
Nov 7, 2023
Water and Electrolytes Content in HYpertension (WHYSKI) in SKIn
Recruiting
- Hyperaldosteronism
- +7 more
- Skin Biopsy
- Video-laparoscopic adrenalectomy
-
Padova, ItalyAzienda Ospedale Università di Padova
Oct 23, 2023
Essential Hypertension, Primary Hypertension Trial (Amicomed®, Digital Placebo, Usual Care)
Not yet recruiting
- Essential Hypertension
- Primary Hypertension
- Amicomed®
- +2 more
- (no location specified)
Oct 19, 2023
Hypertension, Blood Pressure, Systolic Hypertension Trial in Seoul (CART-I Plus)
Recruiting
- Hypertension
- +6 more
- CART-I Plus
-
Seoul, Korea, Republic ofSeoul National Univesity Hospital
Oct 11, 2023
Essential Hypertension Trial in Korea, Republic of (Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg,
Not yet recruiting
- Essential Hypertension
- Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg
- Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg
-
Seoul, Gyeonggi-do, Korea, Republic of
- +11 more
Sep 11, 2023
Aerobic Exercise in Patients With Essential Hypertension
Completed
- Aerobic Exercise
- Essential Hypertension
- Supervised Aerobic Exercise
-
Konya, TurkeySelcuk University Faculty of Medicine
Aug 3, 2023
Essential Hypertension Trial (Azilsartan Medoxomil Potassium Tablet, Nifedipine Sustained -release Tablets, Levoamlodipine
Not yet recruiting
- Essential Hypertension
- Azilsartan Medoxomil Potassium Tablet
- +2 more
- (no location specified)
Jul 21, 2023
Essential Hypertension Trial in Seongnam (D064, D702, of D660, D660, of D064, of D702)
Recruiting
- Essential Hypertension
- D064, D702, placebo of D660
- D660, placebo of D064, placebo of D702
-
Seongnam, Bundang-gu, Korea, Republic ofSeoul National University Bundang Hospital
Jun 27, 2023
Essential Hypertension, Primary Hypercholesterolemia Trial in Seoul (Fimasartan, Ezetimibe/Atorvastatin, Fimasartan Placebo)
Not yet recruiting
- Essential Hypertension
- Primary Hypercholesterolemia
- Fimasartan
- +3 more
-
Seoul, Korea, Republic ofSeverance Hospital
Jun 26, 2023
Essential Hypertension, Endothelial Dysfunction, Inflammation Trial in Timisoara (Black chokeberry juice)
Active, not recruiting
- Essential Hypertension
- +2 more
- Black chokeberry juice
-
Timisoara, Timis, RomaniaASCAR Cardiology Clinic of Timisoara City Hospital
Jun 12, 2023
Essential Hypertension Trial in Changchun (Remote ischemic conditioning, Sham remote ischemic conditioning)
Not yet recruiting
- Essential Hypertension
- Remote ischemic conditioning
- Sham remote ischemic conditioning
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jun 15, 2023
Essential Hypertension Trial in Giza (dynamic neuromuscular stabilization training, balance exercises plus diaphragmatic
Not yet recruiting
- Essential Hypertension
- dynamic neuromuscular stabilization training
- balance exercises plus diaphragmatic breathing
-
Giza, EgyptFaculty of Physical Therapy
Jun 14, 2023
Essential Hypertension Trial (Nerkardou 5 mg & Nerkardou 10 mg)
Not yet recruiting
- Essential Hypertension
- Nerkardou 5 mg & Nerkardou 10 mg
- (no location specified)
May 30, 2023
Essential Hypertension Trial in Bucheon-si (Fimasartan + Indapamide, Fimasartan + Indapamide )
Recruiting
- Essential Hypertension
- Fimasartan + Indapamide
- Fimasartan + Indapamide placebo
-
Bucheon-si, Kyunggi-do, Korea, Republic ofThe Catholic University of Korea, Bucheon St.Mary's Hospital
May 18, 2023
Essential Hypertension Trial in Changchun (Remote ischemic conditioning, Sham remote ischemic conditioning)
Not yet recruiting
- Essential Hypertension
- Remote ischemic conditioning
- Sham remote ischemic conditioning
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Apr 26, 2023
Essential Hypertension, Metabolic Syndrome Trial (Telmisartan, Losartan)
Not yet recruiting
- Essential Hypertension
- Metabolic Syndrome
- (no location specified)
May 3, 2023
Essential Hypertension, Metabolic Cardiovascular Syndrome, Heart Disease Risk Factors Trial in São Paulo (Using the Avatr App)
Active, not recruiting
- Essential Hypertension
- +2 more
- Using the Avatr App
-
São Paulo, BrazilHeart Institute (InCor), Hospital das Clinicas do HCFMUSP
Apr 24, 2023
Essential Hypertension, Diabetes, Type 2 Trial in Seongnam (ATB-1011, ATB-1012, ATB-1013)
Recruiting
- Essential Hypertension
- Diabetes Mellitus, Type 2
- ATB-1011
- +5 more
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Jan 31, 2023
Essential Hypertension Trial in Riyadh (Slow Breathing Exercise (SBE), Progressive Muscle Relaxation (PMR) Technique)
Completed
- Essential Hypertension
- Slow Breathing Exercise (SBE)
- Progressive Muscle Relaxation (PMR) Technique
-
Riyadh, Riyadh 11433, Saudi ArabiaRehabilitation Research Chair, Department of Rehabilitation Scie
Jan 13, 2023
Gut Microbiota of Critical Chronic Diseases in China
Recruiting
- Essential Hypertension
- +10 more
- no intervention
-
Chaoyang, Beijing, China
- +49 more
Dec 16, 2022
Essential Hypertension Trial in Worldwide (Aprocitentan 5 mg, Aprocitentan 10 mg, Aprocitentan 25 mg)
Completed
- Essential Hypertension
- Aprocitentan 5 mg
- +5 more
-
Fort Payne, Alabama
- +90 more
Nov 22, 2022
Essential Hypertension Trial in Changchun (Remote Ischemic Conditioning)
Not yet recruiting
- Essential Hypertension
- Remote Ischemic Conditioning
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Oct 31, 2022